February 19, 2025

Cabaletta’s CABA-201 CAR-T Therapy Shows Promising Results in Lupus and Other Autoimmune Diseases

2 months ago talkbio0Tagged Autoimmune Diseases, B-Lymphocytes, CABA-201, CAR-T, Clinical Trials, Lupus Vulgaris

CABA-201, CAR-T therapy, lupus, autoimmune diseases, clinical trials, remission, B cell depletion

Siemens Healthineers Expands U.S. Supply Chain with Strategic ‘Mega Depots’ to Combat Logistics Challenges

2 months ago talkbio0Tagged Equipment and supply inventories, expansion, GXO, Health care facility, Logistics, mega depots, Partnership, Siemens Healthineers

Siemens Healthineers, supply chain resilience, mega depots, logistics expansion, healthcare equipment, parts inventory, GXO partnership

Ascletis’ Oral GLP-1 Drug Shows Promising Early Results in Obesity Treatment, Rivaling Roche’s Candidate

2 months ago talkbio0Tagged ASC30, Ascletis, Clinical Trials, CT-996, Obesity, Oral cavity, Pharma, Pharmaceutical competition, Product containing glucagon-like peptide 1 receptor agonist (product), Roche (company)

Ascletis Pharma, obesity treatment, oral GLP-1 receptor agonist, ASC30, weight loss, clinical trials, Roche, CT-996, pharmaceutical competition

Legal Challenges Mount Against Trump’s NIH Funding Cuts

2 months ago talkbio0Tagged Economics, Impact food supplement, Indirect, NIH Mouse, research universities, Transitory

NIH funding cuts, indirect costs, research universities, lawsuits, temporary restraining order, economic impact

Supernus Pharmaceuticals’ Stock Plummets as Phase 2b Depression Drug Trial Fails to Meet Primary Endpoint

2 months ago talkbio0Tagged Clinical Trials, decline, Effect, Failure (biologic function), Placebos, SPN-820, Supernus Pharmaceuticals, treatment-resistant depression

Supernus Pharmaceuticals, SPN-820, treatment-resistant depression, clinical trial failure, stock decline, placebo effect

RFK Jr. Backtracks on Vaccine Pledge, Announces Review of Childhood Immunization Schedule

2 months ago talkbio0Tagged CHARGE Syndrome, childhood vaccine schedule, Confirmation, Disease Outbreaks, measles, public health medicine (field), Robert F. Kennedy, Secretary, Senate

Robert F. Kennedy Jr., HHS Secretary, childhood vaccine schedule, review, controversy, public health, measles outbreak, Senate confirmation

GSK’s Penmenvy Approved: New 5-in-1 Meningococcal Vaccine Enters U.S. Market

2 months ago talkbio0Tagged Approved, Invasive meningococcal disease, MenABCWY, Meningococcal vaccine, Penmenvy, SmithKline Beecham, United States Food and Drug Administration, Vaccines

Penmenvy, GSK, meningococcal vaccine, FDA approval, 5-in-1 vaccine, MenABCWY, invasive meningococcal disease (IMD)

Major Budget Cuts and Layoffs Hit US Health Agencies: Impacts on CDC, NIH, and Public Health

2 months ago talkbio0Tagged Administration occupational activities, Centers for Disease Control and Prevention (U.S.), healthcare budget, layoffs, Medical Research activity, NIH Mouse, public health medicine (field), Transplant Registry Unified Management Program

healthcare budget cuts, CDC layoffs, NIH funding reduction, public health impact, Trump administration, federal workforce reduction, medical research funding

Bavarian Nordic’s Vimkunya Approved by FDA as First Chikungunya Vaccine for Ages 12 and Up

2 months ago talkbio0Tagged Adolescent (age group), Approved, Bavarian Nordic, chikungunya vaccine, traveler, United States Food and Drug Administration, Vaccines, Virus-Like Particle, Vimkunya

Vimkunya, chikungunya vaccine, Bavarian Nordic, FDA approval, virus-like particle vaccine, adolescents, travelers

AI-Guided Cardiac Ablation Outperforms Standard Treatment for Persistent Atrial Fibrillation

2 months ago talkbio0Tagged Artificial Intelligence, Atrial Fibrillation, Cardiac ablation, Electrophysiology (science), Medical service, Pulmonary veins, TAILORED-AF

Volta Medical, artificial intelligence, cardiac ablation, atrial fibrillation, TAILORED-AF trial, pulmonary vein isolation, electrophysiology